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1. Abstract  27 
Background: Cardiac resynchronization therapy (CRT) increases the risk of ventricular 28 
tachycardia (VT) in patients with ischemic cardiomyopathy (ICM) when the left 29 
ventricular (LV) epicardial lead is implanted in proximity to scar.  30 
Objective: To determine the mechanisms underpinning this risk, we investigate the 31 
effects of pacing on local electrophysiology (EP) in relation to scar that provides a 32 
substrate for VT in ICM patients undergoing CRT.  33 
Methods: Imaging data from ICM patients (n=24) undergoing CRT were used to create 34 
patient-specific LV anatomical computational models including scar morphology. 35 
Simulations of LV epicardial pacing at 0.2-4.5cm from the scar were performed using 36 
EP models of chronic infarct and heart failure (HF). Dispersion of repolarization and the 37 
vulnerable window were computed, as surrogates of VT risk. 38 
Results: Simulations predict that pacing in proximity to scar (0.2cm) compared to more 39 
distant pacing to a scar (4.5cm) significantly (P<0.01) increased dispersion of 40 
repolarization in the vicinity of the scar and widened (P<0.01) the vulnerable window 41 
increasing the likelihood of uni-directional block. Moreover, slow conduction during HF 42 
further increased dispersion (~194%). ANOVA and post hoc tests show significantly 43 
(P<0.01) reduced repolarization dispersion when pacing 3.5cm or more from the scar 44 
compared to pacing at 0.2cm. 45 
Conclusion: Increased dispersion of repolarization in the vicinity of the scar and 46 
widening of the vulnerable window when pacing in proximity to scar provides a 47 
mechanistic explanation for VT induction in ICM-CRT with lead placement proximal to 48 
scar. Pacing 3.5cm from scar may avoid increasing VT risk in ICM-CRT patients. 49 
Key words: Cardiac resynchronization therapy; ventricular tachycardia; infarct scar; 50 
patient-specific modelling 51 
 52 
 53 
2. Introduction 54 
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Cardiac Resynchronization Therapy (CRT) is an effective treatment for heart failure 55 
(HF). However, CRT-induced ventricular tachycardia (VT) has been reported in patients 56 
with Ischemic Cardiomyopathy (ICM)1–5. 57 
The likelihood of uni-directional block leading to re-entry in ICM-CRT patients is 58 
elevated due to the presence of scar. Dense fibrotic scar core and a border zone (BZ) of 59 
remodeled myocardium6 leads to increased dispersion of repolarization and widening of 60 
the vulnerable window for uni-directional block, which facilitates re-entry. Dispersion of 61 
repolarization is further increased by electrophysiological (EP) changes commonly 62 
found in HF, including slower7 or faster8 conduction and prolongation of action potential 63 
duration (APD)9. Pacing from a LV lead in close proximity to a scar may alter the 64 
activation and repolarization pattern around the scar, increasing the risk of re-entry in 65 
these patients4 despite the potential improvement in cardiac function due to CRT.  66 
The effect of LV pacing in proximity to scar and subsequent increase in VT risk is 67 
unclear, as detailed mapping and pacing at multiple specific locations within a single 68 
patient is inherently challenging. We therefore created patient-specific computational 69 
models of LV anatomy, scar, and BZ to investigate the role of pacing location relative to 70 
scar on VT risk. We ran EP simulations and computed dispersion of repolarization and 71 
the vulnerable window as surrogates for VT risk. 72 
3. Methods 73 
3.1. Patient cohort 74 
Late gadolinium-enhancement magnetic resonance imaging (LGE-MRI) data from 24 75 
ICM-CRT patients were available for this study. After institutional research ethics 76 
committee approval10, patients underwent LGE-MRI assessment before device 77 
implantation and at least 6 months after previous myocardial infarction10. A series of 78 
short-axis slices was acquired with in-plane resolution of 0.6x0.6-1.37x1.37mm2 and 79 
slice thickness of 8-20mm. Demographic characteristics are shown in Table 1. 80 
3.2. Construction of patient-specific models 81 
The pipeline for construction of the patient-specific models is described in the following 82 
sub-sections and the resulting models are shown in Figure S1. 83 
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3.2.1. Image segmentation and processing 84 
LV endocardium and epicardium contours were manually drawn in each short-axis slice 85 
using the image segmentation software Eidolon11. Scar and BZ were segmented as the 86 
regions with signal intensity above 3 and 2 standard deviations from the mean signal 87 
intensity within healthy myocardium, respectively, as described previously10. The 2D 88 
scar and BZ segmentations were reconstructed in 3D using a statistical shape 89 
reconstruction method12. Due to the low in-plane resolution of the images and to 90 
artefacts in the RV, it was not possible to segment the RV wall in this cohort.  91 
3.2.2. Model generation 92 
A finite element tetrahedral mesh was generated by interpolating the LV endocardium 93 
and epicardium contours11. This mesh was then refined to generate a fine (mean edge 94 
length of 0.35mm) and a coarse mesh (mean edge length of 0.8mm) using the C-GAL 95 
library. The 3D reconstructed scar and BZ segmentations were mapped onto the 96 
tetrahedral mesh and used to label mesh elements as scar, BZ, and healthy tissue. 97 
Myofiber orientations were assigned to each anatomical model using a rule-based 98 
method13. Although the models do not include the RV, its absence should not 99 
substantially affect our results, since the RV lead of a CRT device is implanted against 100 
the septum. 101 
3.3. Electrophysiology models and parameters 102 
Activation and repolarization sequences were simulated in the LV models using the 103 
reaction-eikonal model, which allows simulating EP models using coarse spatial 104 
resolutions thus substantially reducing computational cost14. However, this model is not 105 
suitable for conduction block simulations, as activation is triggered at a prescribed time 106 
given by the solution of the eikonal equation14. Thus, the cardiac monodomain model 107 
was employed instead in simulations of conduction block. Both models were coupled to 108 
the ten Tusscher15 model of human ventricular action potential (AP). Simulations were 109 
performed using the Cardiac Arrhythmia Research Package (CARP)14. 110 
As no personalized EP data was available for the patients, we assigned EP parameters 111 
based on the literature. Conduction velocities (CV) were prescribed to the model by 112 
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tuning tissue conductivities using an automatic approach16. Transversely isotropic CV of 113 
0.67 and 0.3m/s in the longitudinal and transverse directions, respectively, were 114 
prescribed to healthy tissue. The BZ was prescribed isotropic CV of 0.15m/s 115 
corresponding to 50% of the transverse CV in healthy tissue, according to 116 
experimentally measured values in the canine epicardial BZ of chronic infarcts6. The 117 
scar core was modelled as unexcitable non-conducting tissue, assuming it consists of 118 
predominantly collagenous non-conducting material. Unless stated otherwise, no 119 
transmural or apico-basal variation of ionic currents was considered. 120 
APD prolongation17 and conduction slowing17,18 have been reported in HF patients. We 121 
investigated the impact of EP changes commonly found in HF by prescribing CVs 20% 122 
slower or faster than healthy/BZ tissue, as reported in rabbit8 and canine7 HF models, 123 
respectively. In addition, a HF ventricular AP model was implemented by altering the 124 
density of ionic currents in the ten Tusscher model, leading to prolonged APD, as 125 
previously described9. 126 
Our EP models were based on chronic infarct6 and HF19 characteristics found in the 127 
literature. However, the EP characteristics of individual patients vary and thus are likely 128 
to affect simulation results. Therefore, we evaluated the impact of our EP modelling 129 
choices on dispersion of repolarization. Specifically, we evaluated the impact of a slow 130 
conducting BZ, apico-basal and transmural APD heterogeneity, different AP models, 131 
and propagation models (Supplement). 132 
3.4. Pacing locations and protocol for simulations of dispersion of repolarization 133 
Pacing locations at 0.2, 0.5, 1.0, 1.5, 2.5, 3.5, and 4.5cm from the scar surface were 134 
chosen for each model  at the mid-scar plane relative to the apex (Figure 1).. These 135 
locations are in agreement with typical lead locations in CRT patients20. Details on the 136 
distances computation are described in the Supplement. 137 
Activation was initiated at each pacing location using a point stimulus (~1mm 138 
circumference) and propagation was simulated for 1s.  139 
3.5. Computing dispersion of repolarization 140 
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Repolarization times were computed as the time when the AP reached a threshold of -141 
70mV after activation. Local repolarization gradients were computed as the magnitude 142 
of the repolarization gradient vector at each mesh node. 143 
We used the volume of tissue with high repolarization gradients (HRG) as a metric of 144 
dispersion of repolarization and a surrogate of VT risk, assuming that the larger the 145 
tissue with HRG, the more likely uni-directional block is to occur in a given heart. A 146 
minimum local repolarization gradient of ~3ms/mm21 is required for the occurrence of 147 
uni-directional block. Thus, the volume of tissue with repolarization gradients above a 148 
threshold of 3ms/mm was computed.  149 
Arrhythmias in ICM patients typically originate within scar or BZ. Thus, we computed the 150 
volume of HRG 0.5, 1.0, and 2.0cm around the scar, and within the whole LV.  151 
3.6. Computing the vulnerable window 152 
To investigate the role of pacing location relative to scar on the vulnerable window, we 153 
simulated premature beats following epicardial LV pacing at different locations. We 154 
used a S1-S2 protocol mimicking the occurrence of ectopic foci within the endocardial 155 
BZ, as observed in ICM. The S1 stimuli were delivered at the epicardial LV lead location 156 
0.2 and 4.5cm from the scar and S2 pacing locations were chosen at the endocardial 157 
BZ ~0.2cm apart (Figure 2). Single premature S2 stimuli were applied at varying 158 
coupling intervals (CI) following the last S1 beat.  159 
The vulnerable window was computed at each S2 pacing location as the difference 160 
between the CI where a stimulus propagated and the smallest CI where uni-directional 161 
block occurred (Supplement). 162 
This part of the study was done for only one of the patient-specific models due to the 163 
high computational cost of computing the vulnerable window. We chose a model with 164 
enough BZ at the endocardium to allow ~20 S2 pacing locations spaced ~0.2cm apart. 165 
3.7. Statistical analysis 166 
Balanced one-way ANOVA with Tukey-Kramer post-hoc tests were used to compare 167 
the volume of HRG (within 0.5, 1, and 2cm from scar and the whole LV) between the 7 168 
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pacing locations. Two sample paired t-tests (Student’s test) were used to compare the 169 
volume of HRG within 1cm from the scar obtained with the HF models and to compare 170 
the vulnerable window when pacing 0.2 and 4.5cm from the scar. Quantitative results 171 
are shown as boxplots. More details are described in the Supplement. 172 
4. Results 173 
4.1. Effect of epicardial pacing on local dispersion of repolarization 174 
We investigated the effect of LV epicardial pacing on local repolarization gradients by 175 
simulating electrical propagation from an LV epicardial lead. This was done for one of 176 
the models in our cohort, where the scar was removed by modelling it as healthy tissue, 177 
thus isolating the effect of pacing. As shown in Figure 3, slower conduction transverse 178 
to the fiber orientation (left) leads to delayed repolarization in this direction, which in turn 179 
leads to large repolarization gradients (right). The local repolarization gradients are 180 
close to 0ms/mm at the pacing site, as the tissue underneath the stimulus site activates 181 
nearly instantly, but increase to 1.8+ and 3.5+ ms/mm longitudinal and transverse to 182 
fibers, respectively. 183 
4.2. Effect of pacing location relative to scar on dispersion of repolarization 184 
We simulated repolarization sequences and computed the volume of HRG using 24 185 
patient-specific models to investigate the role of LV epicardial pacing location relative to 186 
scar on dispersion of repolarization. Figure 4-A) shows the volumes of HRG within 1 cm 187 
around the scar for each pacing location. The plots show a clear trend towards 188 
decreased volumes of HRG within 1cm around the scar when pacing away from the 189 
scar. 190 
The effect of pacing in proximity to scar on the spatial distribution of repolarization 191 
gradients is illustrated in Figure 4 when pacing 0.2 (B) and 2.5cm (C) from scar. Here, 192 
large repolarization gradients appear around the pacing site, as explained in the 193 
previous section, and in the vicinity of the scar, particularly within the BZ, where 194 
conduction is slower. It is worth noting that the scale of 0 to 4ms/mm for the 195 
repolarization gradients was chosen for visualization purposes only and that local 196 
gradients as high as 15ms/mm were found in several cases. 197 
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The same trend, towards a smaller volume of HRG in the vicinity of the scar, is 198 
observed when considering regions 0.5, 1, and 2cm around the scar (Figure S2). 199 
Conversely, when considering the whole LV (Figure S2), this trend disappears and even 200 
reverses when considering the pacing locations at 0.2 and 4.5cm from the scar, where 201 
the total volume of HRG is larger when pacing 4.5cm from the scar.  202 
One-way ANOVA shows statistically significant (P<0.01) differences between pacing 203 
locations considering the regions within 1 and 2cm from the scar. Tukey-Kramer post-204 
hoc tests for these regions show a significantly (P<0.01) larger volume of HRG when 205 
pacing 0.2cm from the scar compared to 3.5 and 4.5cm. More details in the 206 
Supplement. 207 
4.3. Effect of pacing location relative to scar on the vulnerable window 208 
We used a patient-specific model to investigate the impact of pacing location on the 209 
vulnerable window. Figure 5-A) shows an example of uni-directional block following a 210 
S2 stimulus within the BZ at the endocardial surface. Here, the wavefront is blocked in 211 
the gray region, exits at a small region at the bottom of the stimulus and travels around 212 
the region of conduction block. Figure 5-B) shows an example of normal propagation 213 
following a S2 stimulus for comparison. Figure 5-C) shows a boxplot of the vulnerable 214 
window computed at each premature S2 stimuli location when pacing (S1) at the 215 
epicardial surface 0.2 and 4.5cm from the scar (Section 3.6). A significant (P<0.01) 216 
increase in the vulnerable window is observed when pacing 0.2cm from the scar instead 217 
of 4.5cm.  218 
4.4. Effect of electrophysiological changes found in heart failure 219 
We investigated the effect of EP changes commonly found in HF on the relationship 220 
between pacing location relative to scar and the volume of HRG using the HF models, 221 
with 20% faster CV (“fast CV model”), 20% slower CV (“slow CV model”), and with 222 
modified AP (“HF AP model”), as described in Section 3.3, and compared these with our 223 
“base model” with normal CV within the LV and slow CV in the BZ and with normal AP 224 
properties. Figure 6 shows the effect of each HF model on the volume of HRG within 225 
1cm from the scar when pacing 0.2 and 4.5cm from the scar. Panels A and B show the 226 
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spatial distribution of local repolarization gradients for one patient-specific model when 227 
pacing 0.2 and 4.5cm from scar, respectively. Panel C show the volume of HRG for all 228 
patient-specific models and each HF model. The volume of HRG is significantly 229 
(P<0.01) smaller when pacing 4.5cm from scar than from 0.2cm in all cases. The effect 230 
is most and least visible in the case of slower and faster conduction, respectively. APD 231 
prolongation has little effect compared with the base model.  232 
5. Discussion 233 
Recent clinical studies provided empirical evidence that pacing in proximity to scar can 234 
cause VT in ICM-CRT patients4. However, the underlying VT mechanisms remained 235 
unclear. Thus, we investigated the interaction between pacing electrode location relative 236 
to scar on VT risk in ICM-CRT patients. We used computational models of patient-237 
specific anatomy and computed local repolarization gradients and the vulnerable 238 
window, as surrogates of VT risk, based on their known link to arrhythmogenesis. Our 239 
main finding is that pacing at the epicardial surface in proximity to scar increases the 240 
volume of HRG and widens the vulnerable window in the vicinity of the scar. This 241 
provides a plausible mechanistic explanation for increased VT risk in ICM-CRT patients. 242 
The risk of VT was further augmented by EP changes commonly found in HF 243 
5.1. Mechanisms of increased VT risk when pacing in proximity to scar 244 
When pacing at the epicardial surface via an LV lead (point stimulus), the propagating 245 
wavefront has a convex shape. A curved wavefront propagates more slowly than a 246 
planar wavefront, thus, increasing dispersion of repolarization around the pacing site, 247 
particularly transverse to the fiber direction, where propagation is slower than parallel to 248 
it (Figure 4). When pacing in proximity to scar, the wavefront reaches the scar with 249 
larger curvature than when pacing away from it. This thus enhances dispersion of 250 
repolarization and increases the volume of HRG in the vicinity of the scar (Figure 4). 251 
Increased dispersion of repolarization widens the vulnerable window for the occurrence 252 
of uni-directional block. Our study demonstrates that pacing in proximity to scar  also 253 
widens the vulnerable window. Thus, there is both a larger volume of tissue and a 254 
longer time interval where uni-directional block may be induced when pacing in 255 
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proximity to scar. It is therefore logical that pacing in proximity to scar will increase the 256 
likelihood of re-entry in ICM-CRT patients, as observed clinically4. Moreover, based on 257 
the trend of decreased volume of HRG in the vicinity of the scar when pacing away from 258 
it and on the post-hoc test results, pacing more than 3.5cm from the scar is likely to 259 
avoid increasing susceptibility to re-entry.  260 
It is worth noting that the morphology of the scar/BZ varies substantially in our cohort 261 
(Figure S1) and are likely to influence the occurrence of re-entry in an individual patient. 262 
Although we have computed the vulnerable window for a single patient, owing to the 263 
large computational cost of the simulations, the volume of HRG was computed for all 264 
patients and thus account for variability of scar/BZ morphology. 265 
5.2. Impact of HF on VT risk 266 
Slow CV reported in HF7,17,18 widens the vulnerable window, predisposing patients to re-267 
entry. This scenario may be particularly dangerous with increased heart size during HF, 268 
where the wavelength to heart size ratio is reduced thus facilitating re-entry7. 269 
Conversely, HF has also been associated with increased CV due to increased cell size8. 270 
While increased CV may be anti-arrhythmogenic, as it increases the wavelength, it may 271 
facilitate re-entry if the increase is heterogeneously distributed throughout the heart 272 
increasing dispersion of repolarization. 273 
Prolongation of APD17 due to reduced potassium currents22 is common in HF. Reduced 274 
potassium current reduces repolarization reserve, which facilitates the occurrence of 275 
early after depolarizations (EADs). At the tissue scale, local EADs can synchronize and 276 
propagate, leading to re-entry, particularly in the scenario of decreased tissue 277 
coupling23.  278 
In this study, we demonstrated that EP changes commonly found in HF affect the 279 
volume of HRG within 1cm from scar, with slower conduction substantially increasing it 280 
(Figure 6). Conversely, the volume of HRG remains larger when pacing in proximity to 281 
scar. These results highlight that pacing in proximity to scar may increase VT risk 282 
regardless of the underlying EP properties, but may be particularly harmful in the 283 
presence of slow conduction.  284 
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5.3. Impact of model choice 285 
In this study, we did not personalize EP, as invasive EP data, such as electro-286 
anatomical mapping, was not available. However, we investigated the impact of EP 287 
model choice and assumptions on our results using alternative cell models (ten 288 
Tusscher, O’Hara-Rudy, Grandi – Figure S3), the monodomain model (Figure S4), and 289 
various model parameters that account for EP spatial heterogeneity (transmural and 290 
apico-basal APD heterogeneity and a slow conducting BZ – Figure S3). Our results 291 
(Figure S3-S4) show that, although the total volume of HRG varied with the presence of 292 
spatial EP heterogeneity and with different EP models, the relationship between pacing 293 
location and the volume of HRG is consistent and statistically significant across all 294 
models, with smaller volume when pacing away from the scar. 295 
5.4. Comparison with previous studies 296 
Recent clinical studies have described CRT-induced arrhythmias1–5, particularly, in ICM 297 
patients1–3,5 and when pacing near scar4. However, the underlying EP changes induced 298 
by pacing near scar that give rise to VT remained unknown. This study is, to the best of 299 
our knowledge, the first to provide a mechanistic explanation for increased VT risk in 300 
ICM-CRT patients when pacing in proximity to scar. Our results are in agreement with 301 
the experimental and clinical literature that suggests that patients with scar and HF are 302 
intrinsically at higher risk of VT due to EP changes and that this is further enhanced by 303 
pacing in proximity to scar4. 304 
5.5. CRT in ICM patients 305 
Current CRT guidelines recommend that pacing leads should be implanted away from 306 
scar to improve response to treatment, with reports of VT when pacing near scar4 307 
further strengthening the argument against pacing in the proximity of scar. However, 308 
how far from a scar is safe to pace remained unknown. We showed that pacing away 309 
from a scar decreases the volume of HRG in its vicinity, particularly pacing more than 310 
3.5cm from the scar. This suggests that pacing ~3.5cm from a scar may avoid 311 
increasing VT risk in ICM-CRT patients. 312 
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Epicardial lead placement is limited by the anatomy of the coronary sinus, which makes 313 
it difficult to avoid pacing in/near scar. Moreover, pacing away from a scar may result in 314 
suboptimal resynchronization.  Multi-site and endocardial pacing may offer feasible 315 
alternatives to conventional CRT in ICM patients. Multi-site pacing allows pacing from 316 
multiple locations, maximizing resynchronization, and modifying these over time should 317 
they prove arrhythmogenic3. Endocardial pacing allows pacing anywhere within the 318 
endocardial surface thus facilitating pacing within an optimal region while avoiding scar. 319 
In addition, measuring the stimulus to QRS interval (S-QRS) may allow identifying 320 
optimal pacing sites while avoiding scar24. 321 
It is worth noting that the impact of pacing in proximity to the scar was independent on 322 
scar location within the LV. In 17 patients, who had scar in the septum, pacing in 323 
proximity to the scar caused the same increase in volume of HRG as when the scar was 324 
located in the LV free wall. This would support also placing the RV lead away from scar 325 
if possible. 326 
6. Conclusions 327 
LV epicardial pacing in proximity to scar increased the volume of tissue with HRG and 328 
widened the vulnerable window for uni-directional block. In addition, the presence of 329 
slow conduction, commonly found in HF, further increased the volume of  HRG. Our 330 
study thus provides a plausible mechanistic explanation for increased VT risk in ICM-331 
CRT patients when pacing in proximity to scar. Our results also suggest that pacing 332 
3.5cm or more from the scar may avoid increasing VT risk in ICM-CRT patients. 333 
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Characteristic Value 
Age 69.1±9.5 
Sex: male 20 (83) 
LBBB 11 (46) 
QRS duration 133.6±25.7  
LV ejection fraction (%) 30.8±12.7 
Table 1 Demographic characteristics. Values are presented as mean ± standard 428 
deviation or as n (%). LBBB: left bundle branch block. LV: left ventricular. 429 
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 431 
Figure 1: Pacing locations (green) relative to scar (black). Orange indicates distances 432 
from scar. The blue plane indicates the mid-scar plane located 5 cm from the apex. 433 
  434 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
18 
 
 435 
Figure 2: Location of S1 and S2 stimuli. Left: S1 stimuli locations at the epicardium 436 
surface 0.2 and 4.5 cm from the scar (blue spheres). Right: twenty-one S2 pacing 437 
locations (yellow spheres) selected on the endocardium surface within the border zone 438 
(BZ). 439 
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 441 
Figure 3: Activation times (ms) and repolarization gradients (ms/mm) following a point 442 
stimulus on the LV epicardial surface of one of the models in our cohort, where the scar 443 
was modelled as healthy tissue. Left: Isochrones are 10 ms apart. Location of the 444 
epicardial lead is indicated by pink circle. Fiber orientation on epicardial surface is 445 
indicated by the black arrow. Right: spatial distribution of local repolarization gradients 446 
corresponding to the activation sequence shown on the left. Large repolarization 447 
gradients (red) spread away from the pacing site in the direction transverse to fibers. 448 
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 450 
Figure 4 A) Volumes of high repolarization gradients (HRG) within 1cm around the scar 451 
relative to pacing distance from scar. P-values are displayed and n.s. stands for non-452 
significant. B,C) Example of repolarization gradients within the LV epicardial surface for 453 
one of the models when pacing 0.2 cm (B) and 2.5 cm (C) from the scar. The white 454 
curves indicate the region 1 cm around the scar. The core of the scar is shown in black. 455 
Filled white circles indicate the location of the LV epicardial lead. 456 
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 458 
Figure 5 A) Example of uni-directional block and B) normal propagation following an S2 459 
stimulus. C) Vulnerable window (ms) at each S2 pacing location when the LV lead is 460 
located 0.2 and 4.5 cm from the scar. An increase in the vulnerable window is observed 461 
when pacing in proximity to scar compared to pacing away from it.  462 
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 464 
Figure 6: Effect of electrophysiological (EP) changes commonly found in heart failure 465 
(HF) on the volume of high repolarization gradients (HRG) within 1 cm around the scar 466 
when pacing 0.2 and 4.5 cm from the scar. From left to right: “Base model” refers to the 467 
model with normal conduction velocity (CV) within the left ventricle, slow CV within the 468 
border zone (BZ), and normal action potential (AP) morphology; “Fast CV model” and 469 
“Slow CV model” refer to models with 20% faster and slower CV within LV and BZ 470 
relative to values of the “Base model”, respectively; and “HF AP model” refers to the 471 
model with increased APD. Panels A) and B) show examples of the spatial distribution 472 
of local repolarization gradients when pacing 0.2 and 4.5 cm from scar, respectively. C) 473 
Panels show plots of the volume of HRG within 1 cm around the scar when pacing 0.2 474 
and 4.5 cm from scar for each EP model. 475 
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